105 related articles for article (PubMed ID: 6396466)
21. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
22. [T and B lymphocyte subpopulations with HLA-DR surface molecules in rheumatoid arthritis, using a monoclonal lymphocytotoxic antibody. Poorly and highly developed rheumatoid arthritis].
Mercier P; Dallest R; Olmeta C; Gaborit P; Gatti P; Roux H
Rev Rhum Mal Osteoartic; 1981 Nov; 48(11):713-9. PubMed ID: 6975966
[TBL] [Abstract][Full Text] [Related]
23. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
[TBL] [Abstract][Full Text] [Related]
24. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
25. [Cellular interactions during immune response (author's transl)].
Huber C
Acta Med Austriaca; 1982; 9(1):19-21. PubMed ID: 6461998
[TBL] [Abstract][Full Text] [Related]
26. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
27. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
29. Characterization of B- and T-cell responses and HLA-DR4 binding motifs of the latex allergen Hev b 6.01 (prohevein) and its post-transcriptionally formed proteins Hev b 6.02 and Hev b 6.03.
Raulf-Heimsoth M; Rozynek P; Brüning T; Rihs HP
Allergy; 2004 Jul; 59(7):724-33. PubMed ID: 15180759
[TBL] [Abstract][Full Text] [Related]
30. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.
Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Muramatsu M; Yamaguchi K; Fukuhara S
J Cancer Res Clin Oncol; 2002 Nov; 128(11):581-8. PubMed ID: 12458337
[TBL] [Abstract][Full Text] [Related]
31. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.
Kumagai S; Steinberg AD; Green I
J Clin Invest; 1981 Mar; 67(3):605-14. PubMed ID: 6970750
[TBL] [Abstract][Full Text] [Related]
33. [Immunological reactivity of patients with simple psoriasis. II. T-lymphocyte markers in TE rosette tests].
Turowski G; Kapińska-Mrówka M
Przegl Dermatol; 1980; 67(6):723-8. PubMed ID: 6972551
[No Abstract] [Full Text] [Related]
34. Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA.
Troye-Blomberg M; Olerup O; Perlmann H; Larsson A; Elghazali G; Fogdell A; Jepsen A; Lepers JP; Pandey JP; Grunewald J
Behring Inst Mitt; 1994 Dec; (95):97-105. PubMed ID: 7755513
[TBL] [Abstract][Full Text] [Related]
35. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
[TBL] [Abstract][Full Text] [Related]
36. Fate of antibodies bound to lymphocyte surface. II.--Degradation and release of immune complexes.
Robert M; Vincent C; Arnaud P; Revillard JP
Ann Immunol (Paris); 1976; 127(2):145-61. PubMed ID: 938000
[TBL] [Abstract][Full Text] [Related]
37. [T- and B-systems of immunity in psoriasis].
Sizov IE
Vestn Dermatol Venerol; 1978 Sep; (9):40-3. PubMed ID: 309249
[No Abstract] [Full Text] [Related]
38. On cell-mediated immune response in psoriatic patients.
Angelini G; Vena GA; Lomuto M; Meneghini CL
Acta Derm Venereol Suppl (Stockh); 1979; 87():29-30. PubMed ID: 316955
[No Abstract] [Full Text] [Related]
39. Immunologic abnormalities in psoriasis: the inhibition of leucocyte migration by stratum corneum antigens.
Gliński W; Haftek M; Obałek S; Sochor H
Dermatologica; 1978; 156(4):231-7. PubMed ID: 624432
[TBL] [Abstract][Full Text] [Related]
40. [The immunological mechanisms of psoriasis].
Cormane RH; Hunyadi J; Hamerlinck F
Ann Dermatol Syphiligr (Paris); 1976; 103(5-6):567-72. PubMed ID: 138379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
